Skip to main content
Equibles

Man Group plc

Position in FATE — Fate Therapeutics Inc

CIK 1637460 LONDON, X0
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$475,488
-$40,599 QoQ
Shares Held
176,107
-59.1% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 156 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. FATE ranks #95 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5 APGE
Apogee Therapeutics, Inc.
 397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in FATE

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $475,488 176,107
2026-03-31 $516,087 430,073
2025-12-31 $255,948 261,172
2025-09-30 $276,769 219,658
2023-12-31 $945,008 252,676
2023-09-30 $462,590 218,203
2023-06-30 $827,954 173,940
2023-03-31 $404,779 71,014
2022-12-31 $946,813 93,837
2022-09-30 $387,692 17,300
2021-12-31 $727,279 12,430
2021-03-31 $512,179 6,212
2020-12-31 $7,212,840 79,323
2020-09-30 $4,208,840 105,300
2020-06-30 $932,099 27,167